Established in 2010,focused on infectious disease diagnostic solution for over 10 years.
Bioperfectus became the 1st molecular diagnostic company to land on the Sci-tech Innovation Board of Shanghai Stock Exchange (SSE code: 688399).
Provide integrated and advanced total diagnostic solution to clinical laboratories and CDC all over the world.